Inhibition of JAK2 using the non-selective compound AG490 has demonstrated that JAK2 activity is required for STAT3 phosphorylation and viral oncogene expression in HPV+ cervical cancer cells [47]. The gene discussed is STAT3; the disease is cervical carcinoma.